We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+27.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.73B
AUM Growth
+$371M
Cap. Flow
-$511M
Cap. Flow %
-10.8%
Top 10 Hldgs %
7.01%
Holding
1,405
New
92
Increased
215
Reduced
417
Closed
102

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$19.8M
2
CL icon
Colgate-Palmolive
CL
+$18.1M
3
FOXA icon
Fox Class A
FOXA
+$17.4M
4
WRK
WestRock Company
WRK
+$17M
5
ROL icon
Rollins
ROL
+$17M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$27.9M
2
AMGN icon
Amgen
AMGN
+$25.5M
3
PFE icon
Pfizer
PFE
+$24.6M
4
WM icon
Waste Management
WM
+$23.8M
5
SUI icon
Sun Communities
SUI
+$22.3M

Sector Composition

Rank Sector Weight
1 Financials 23.79%
2 Technology 12.1%
3 Industrials 11.16%
4 Healthcare 10.96%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESGR
1001
DELISTED
Enstar Group
ESGR
$430K 0.01%
2,100
– –
LGL icon
1002
LGL Group
LGL
$46.5M
$429K 0.01%
90,698
– –
PED icon
1003
PEDEVCO
PED
$141M
$429K 0.01%
14,210
– –
PHAS
1004
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$429K 0.01%
127,600
-25,000
-16% -$89.5K
POWI icon
1005
Power Integrations
POWI
$3.61B
$426K 0.01%
5,200
-600
-10% -$40.7K
RMTI icon
1006
Rockwell Medical
RMTI
$28.2M
$425K 0.01%
3,822
-454
-11% -$50.8K
FRTA
1007
DELISTED
Forterra, Inc
FRTA
$425K 0.01%
24,700
-5,200
-17% -$83.3K
MACK
1008
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$425K 0.01%
61,700
– –
YORW icon
1009
York Water
YORW
$514M
$424K 0.01%
9,100
+900
+11% +$41.2K
TTEC icon
1010
TTEC Holdings
TTEC
$124M
$423K 0.01%
5,800
-600
-9% -$38.9K
MEDP icon
1011
Medpace
MEDP
$16.5B
$418K 0.01%
3,000
– –
AIRI icon
1012
Air Industries Group
AIRI
$12.8M
$416K 0.01%
33,820
+10,000
+42% +$117K
SIGI icon
1013
Selective Insurance
SIGI
$5.73B
$415K 0.01%
6,200
– –
CNMD icon
1014
CONMED
CNMD
$1.47B
$414K 0.01%
3,700
-700
-16% -$66.3K
INVA icon
1015
Innoviva
INVA
$1.48B
$414K 0.01%
33,400
+3,900
+13% +$42.1K
MCBS icon
1016
MetroCity Bankshares
MCBS
$1.03B
$414K 0.01%
+28,700
New +$410K
CORT icon
1017
Corcept Therapeutics
CORT
$12B
$413K 0.01%
15,800
-1,600
-9% -$33.7K
RDUS
1018
DELISTED
Radius Health, Inc.
RDUS
$413K 0.01%
23,100
-6,100
-21% -$91.6K
BDR
1019
DELISTED
Blonder Tongue Laboratories Inc
BDR
$412K 0.01%
310,100
– –
OVBC icon
1020
Ohio Valley Banc Corp
OVBC
$205M
$411K 0.01%
17,400
– –
KTCC icon
1021
Key Tronic
KTCC
$44.7M
$410K 0.01%
59,433
-25,800
-30% -$211K
RNDB
1022
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
$410K 0.01%
18,600
– –
BBGI icon
1023
Beasley Broadcasting Group
BBGI
$40M
$409K 0.01%
13,741
– –
NSA
1024
DELISTED
National Storage Affiliates Trust
NSA
$407K 0.01%
+11,300
New +$390K
ATSG
1025
DELISTED
Air Transport Services Group
ATSG
$407K 0.01%
13,000
-1,600
-11% -$46.7K
39 40
41
42 43

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Bridgeway Capital Management held 1,405 positions worth $4.73B, up 8.5% from $4.36B the previous quarter. Its ten largest holdings account for 7% of the portfolio.

Bridgeway Capital Management withdrew a net $511M in Q4 2020, closing 102 positions and reducing 417 holdings. Its most notable exit was Micron Technology, an estimated $27.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Abbott worth $19.9M.

  • Bridgeway Capital Management's largest Q4 2020 buy was Abbott: 182,150 shares worth $19.9M.
  • Bridgeway Capital Management added most to Rollins in Q4 2020, an estimated $17M increase.
  • Bridgeway Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $24.6M.
  • Bridgeway Capital Management fully exited Micron Technology in Q4 2020, selling an estimated $27.9M.
  • Bridgeway Capital Management's ten largest holdings make up 7% of its $4.73B portfolio in Q4 2020.
  • Bridgeway Capital Management opened 92 new positions and closed 102 in Q4 2020.
  • Bridgeway Capital Management's portfolio value rose 8.5% quarter-over-quarter to $4.73B.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.